English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113656/144643 (79%)
Visitors : 51720778      Online Users : 614
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version
    政大機構典藏 > 法學院 > 法律學系 > 期刊論文 >  Item 140.119/80647


    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/80647


    Title: 藥品市場產品跳躍行為之競爭法研究：以美歐實務案例為中心
    Other Titles: Product Hopping in the Pharmaceutical Market: Critical Assessment in Light of US and EU Cases and Competition Law Principles
    Authors: 王立達;邱靖芳
    Contributors: 法學院
    Keywords: 醫藥專利;學名藥上市許可;學名藥替代制度(DPS);獨占濫用;合理原則;Pharmaceutical Patents;Generic Drug Marketing Approval;Drug Product Selection Laws;Monopolization;Rule of Reason
    Date: 2015.11
    Issue Date: 2016-01-18 16:08:36 (UTC+8)
    Abstract: 產品跳躍行為是專利藥廠近十年間新發展的競爭策略。截至目前為止，美歐至少有四件作成實體裁判的案件，對於是否違反競爭法及其具體判斷標準，法院在不同個案中所表示看法亦有所不同。產品跳躍行為的操作策略多會搭配所處國家相關管制規範而因地制宜，產品跳躍的具體型態與強度在不同案例中亦有所不同，凡此更增添本議題之複雜度。本文將介紹美歐實務案例之事實背景與法院見解，分析法院判斷標準的差異並且評析可能引發的問題，最終回歸競爭法理進行統整分析，試圖尋找出競爭法上適當之違法判斷標準。
    Product hopping is one type of competitive strategies developed by brand-name pharmaceutical companies in the past ten years. The hopping conducts varied in terms of their specifics and strength, and were individually adapted to the pharmaceutical regulations in different countries. To date there have been at least four pertinent judicial decisions delivered in Europe or the United States, where the courts substantially diverged on the conclusion and appropriate test for their compatibility with the rules of competition law. This paper investigates the facts and opinions of those judicial cases, analyzes the difference and the whole picture of their rulings, and identifies possible problems. On that basis, the adequate test and key facts for assessing the legitimacy of product hopping will be put forth accordingly.
    Relation: 月旦財經法, No.37
    Data Type: article
    DOI 連結: http://dx.doi.org/10.3966/1815008X2015110037005
    DOI: 10.3966/1815008X2015110037005
    Appears in Collections:[法律學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML2719View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback